Search research articles
Contact Us
Filters
Showing results (331-340 of 484) with videos related to
Page
of 49
Sort By:
Clinical Science (London, England : 1979)
|
January 9, 2016
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis
Iona C Evans, Josephine L Barnes, Ian M Garner, et al.
Clinical and Experimental Rheumatology
|
July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
Robert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
BMC Musculoskeletal Disorders
|
February 8, 2012
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol
Begonya Alcacer-Pitarch, Maya H Buch, Janine Gray, et al.
The Journal of Biological Chemistry
|
March 27, 2004
Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK
Shi-wen Xu, Sarah L Howat, Elisabetta A Renzoni, et al.
Arthritis Care & Research
|
August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosis
Lorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
Genome Medicine
|
March 24, 2017
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
Jaclyn N Taroni, Casey S Greene, Viktor Martyanov, et al.
Clinical and Experimental Rheumatology
|
August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale
Dinesh Khanna, Christopher P Denton, Shervin Assassi, et al.
Journal of the American College of Cardiology
|
June 27, 2009
Updated clinical classification of pulmonary hypertension
Gérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
Annals of the Rheumatic Diseases
|
July 7, 2021
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis
Kristina Elizabeth Neergaard Clark, Corrado Campochiaro, Eszter Csomor, et al.
Arthritis Research & Therapy
|
October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
Page
of 49
Search research articles
Search
Showing results (331-340 of 484) with videos related to
Sort By:
Page
of 49
Clinical Science (London, England : 1979)
|
January 9, 2016
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis
Iona C Evans, Josephine L Barnes, Ian M Garner, et al.
Clinical and Experimental Rheumatology
|
July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
Robert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
BMC Musculoskeletal Disorders
|
February 8, 2012
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol
Begonya Alcacer-Pitarch, Maya H Buch, Janine Gray, et al.
The Journal of Biological Chemistry
|
March 27, 2004
Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK
Shi-wen Xu, Sarah L Howat, Elisabetta A Renzoni, et al.
Arthritis Care & Research
|
August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosis
Lorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
Genome Medicine
|
March 24, 2017
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
Jaclyn N Taroni, Casey S Greene, Viktor Martyanov, et al.
Clinical and Experimental Rheumatology
|
August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale
Dinesh Khanna, Christopher P Denton, Shervin Assassi, et al.
Journal of the American College of Cardiology
|
June 27, 2009
Updated clinical classification of pulmonary hypertension
Gérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
Annals of the Rheumatic Diseases
|
July 7, 2021
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis
Kristina Elizabeth Neergaard Clark, Corrado Campochiaro, Eszter Csomor, et al.
Arthritis Research & Therapy
|
October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
Page
of 49